Addiction motivation reformulated: an affective processing model of negative reinforcement.
Timothy B Baker, Megan E Piper, Danielle E McCarthy...
https://pubmed.ncbi.nlm.nih.gov/14756584Actively Recruiting
Led by Yale University · Updated on 2025-02-28
180
Participants Needed
1
Research Sites
N/A
Total Duration
Y
Yale University
Lead Sponsor
N
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborating Sponsor
Researchers are investigating how brain processes related to pain avoidance learning may be different in individuals with opioid use disorder (OUD) compared to healthy people. The study explores whether those with OUD have trouble learning to avoid pain and how this relates to their brain activity. It also aims to find out if these brain processes can predict future opioid use or relapse in people with OUD. Participants include individuals diagnosed with OUD who are seeking treatment, regular opioid users not seeking treatment, and healthy controls matched by age, sex, race, and education. Participants will perform a learning task inside an fMRI scanner to assess avoidance and reward learning through a probabilistic go/no-go task involving cues to avoid electric shocks or gain rewards. The study includes a 12-month follow-up period for those with OUD to monitor opioid use and relapse. During the study, participants undergo clinical assessments, neuroimaging, and physiological recordings on the first day. The primary outcomes measured include avoidance learning performance, brain activity during the learning task, and opioid use over the 12-month follow-up. Secondary outcomes compare learning and brain activity differences between women and men. Participants must be physically healthy and able to complete study tasks, with safety monitoring such as MRI compatibility checks. The total participation period includes initial testing and one year of follow-up for opioid use monitoring.
CONDITIONS
Opioid Use Disorder and Pain
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo neuroimaging, physiological recordings, and clinical assessments to evaluate avoidance and reward learning related to opioid use disorder.
1 baseline visit (in-person)
Duration - 12 months
Participants are followed up for 12 months to monitor opioid use and identify predictors of relapse.
Follow-up interviews during the 12-month period
Total: 1 location
1
Connecticut Mental Health Center, S105
New Haven, Connecticut, United States, 06519
Actively Recruiting
T
Thang M Le, PhD
C
Chiang-shan R Li, MD, PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Timothy B Baker, Megan E Piper, Danielle E McCarthy...
https://pubmed.ncbi.nlm.nih.gov/14756584Luis M Carcoba, Arturo E Contreras, Antonio Cepeda-Benito...
https://pubmed.ncbi.nlm.nih.gov/21745048Zhen-Yu Ren, Jie Shi, David H Epstein...
https://pubmed.ncbi.nlm.nih.gov/19172249Christine E Grella, Katherine Lovinger
https://pubmed.ncbi.nlm.nih.gov/21549528Thang M Le, Simon Zhornitsky, Wuyi Wang...
https://pubmed.ncbi.nlm.nih.gov/31746092Wuyi Wang, Simon Zhornitsky, Thang M Le...
https://pubmed.ncbi.nlm.nih.gov/32061544Thang M Le, Herta Chao, Ifat Levy...
https://pubmed.ncbi.nlm.nih.gov/32587547Thang M Le, Sheng Zhang, Simon Zhornitsky...
https://pubmed.ncbi.nlm.nih.gov/31747630